Chemed EBITDA 2010-2024 | CHE
Chemed annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Chemed EBITDA for the quarter ending December 31, 2024 was $0.130B, a 2.19% increase year-over-year.
- Chemed EBITDA for the twelve months ending December 31, 2024 was $0.430B, a 6.93% increase year-over-year.
- Chemed 2024 annual EBITDA was $0.43B, a 6.93% increase from 2023.
- Chemed 2023 annual EBITDA was $0.402B, a 0.25% decline from 2022.
- Chemed 2022 annual EBITDA was $0.403B, a 0.15% increase from 2021.
Chemed Annual EBITDA
(Millions of US $) |
| 2024 |
$430 |
| 2023 |
$402 |
| 2022 |
$403 |
| 2021 |
$402 |
| 2020 |
$447 |
| 2019 |
$303 |
| 2018 |
$283 |
| 2017 |
$150 |
| 2016 |
$216 |
| 2015 |
$221 |
| 2014 |
$206 |
| 2013 |
$176 |
| 2012 |
$196 |
| 2011 |
$192 |
| 2010 |
$180 |
| 2009 |
$161 |
Chemed Quarterly EBITDA
(Millions of US $) |
| 2024-12-31 |
$130 |
| 2024-09-30 |
$108 |
| 2024-06-30 |
$104 |
| 2024-03-31 |
$88 |
| 2023-12-31 |
$127 |
| 2023-09-30 |
$102 |
| 2023-06-30 |
$85 |
| 2023-03-31 |
$88 |
| 2022-12-31 |
$96 |
| 2022-09-30 |
$96 |
| 2022-06-30 |
$107 |
| 2022-03-31 |
$104 |
| 2021-12-31 |
$112 |
| 2021-09-30 |
$107 |
| 2021-06-30 |
$88 |
| 2021-03-31 |
$95 |
| 2020-12-31 |
$158 |
| 2020-09-30 |
$89 |
| 2020-06-30 |
$107 |
| 2020-03-31 |
$93 |
| 2019-12-31 |
$92 |
| 2019-09-30 |
$76 |
| 2019-06-30 |
$76 |
| 2019-03-31 |
$60 |
| 2018-12-31 |
$78 |
| 2018-09-30 |
$71 |
| 2018-06-30 |
$68 |
| 2018-03-31 |
$66 |
| 2017-12-31 |
$66 |
| 2017-09-30 |
$63 |
| 2017-06-30 |
$-30 |
| 2017-03-31 |
$51 |
| 2016-12-31 |
$62 |
| 2016-09-30 |
$52 |
| 2016-06-30 |
$48 |
| 2016-03-31 |
$54 |
| 2015-12-31 |
$59 |
| 2015-09-30 |
$59 |
| 2015-06-30 |
$53 |
| 2015-03-31 |
$49 |
| 2014-12-31 |
$59 |
| 2014-09-30 |
$49 |
| 2014-06-30 |
$51 |
| 2014-03-31 |
$47 |
| 2013-12-31 |
$50 |
| 2013-09-30 |
$40 |
| 2013-06-30 |
$36 |
| 2013-03-31 |
$50 |
| 2012-12-31 |
$56 |
| 2012-09-30 |
$47 |
| 2012-06-30 |
$49 |
| 2012-03-31 |
$44 |
| 2011-12-31 |
$56 |
| 2011-09-30 |
$51 |
| 2011-06-30 |
$45 |
| 2011-03-31 |
$40 |
| 2010-12-31 |
$48 |
| 2010-09-30 |
$46 |
| 2010-06-30 |
$43 |
| 2010-03-31 |
$43 |
| 2009-12-31 |
$40 |
| 2009-09-30 |
$41 |
| 2009-06-30 |
$37 |
| 2009-03-31 |
$43 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$8.501B |
$2.431B |
|
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
|
